This website will be unavailable from Friday, April 26, 2024 at 6:00 p.m. through Monday, April 29, 2024 at 7:00 a.m. due to data center maintenance.

  80R6843 JTS-F
 
  By: Deshotel, Delisi, Bonnen, H.B. No. 1379
      Howard of Travis, et al.
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to human papilloma virus education programs.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Subchapter A, Chapter 161, Health and Safety
  Code, is amended by adding Section 161.0107 to read as follows:
         Sec. 161.0107.  HUMAN PAPILLOMA VIRUS; VACCINES EDUCATION
  MATERIALS.  The department, using existing resources, shall produce
  and distribute informational materials regarding vaccines against
  human papilloma virus that are approved by the United States Food
  and Drug Administration for human use. The materials must include
  information relating to the effectiveness, availability, and
  contraindications of the vaccines.
         SECTION 2.  Chapter 163, Health and Safety Code, is amended
  by adding Section 163.003 to read as follows:
         Sec. 163.003.  ADDITIONAL INSTRUCTIONAL ELEMENTS REGARDING
  HUMAN PAPILLOMA VIRUS.  Course materials and instruction relating
  to sexually transmitted diseases should include:
               (1)  the following specific information on human
  papilloma virus:
                     (A)  that sexual intercourse is not required to
  become infected with human papilloma virus and that the avoidance
  of skin-to-skin contact involving the genital areas offers the best
  protection;
                     (B)  that both males and females may be infected
  with human papilloma virus and symptoms may not be present;
                     (C)  that younger women are at greater risk of
  human papilloma virus infection than older women; and
                     (D)  that human papilloma virus may be transmitted
  to an infant during childbirth;
               (2)  information regarding the role of human papilloma
  virus in the development of genital warts, cervical cancer, and
  other diseases; and
               (3)  information regarding the continuing need for
  women to undergo pap smear testing, even if they have received a
  vaccination against human papilloma virus.
         SECTION 3.  This Act takes effect September 1, 2007.